Quantification of Hepatitis B Core Antibody Helps Predict Clinical Relapse After Cessation of Nucleos(t)ide Analogues in Chronic Hepatitis B Patients: More Needs to Be Done Reply

H. Chi (Heng), Peng, J. and Janssen, HLA

2019

Additional Metadata
Persistent URL	doi.org/10.1016/j.cgh.2018.09.002, hdl.handle.net/1765/116325
Journal	Clinical Gastroenterology and Hepatology
Organisation	Department of Orthopaedics
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Chi, H., Peng, J., & Janssen, HLA. (2019). Quantification of Hepatitis B Core Antibody Helps Predict Clinical Relapse After Cessation of Nucleos(t)ide Analogues in Chronic Hepatitis B Patients: More Needs to Be Done Reply. Clinical Gastroenterology and Hepatology, 17(5), 1001–1002. doi:10.1016/j.cgh.2018.09.002

Publication